✦ LIBER ✦

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

✍ Scribed by N. Julian H. Sturt; Robin K. S. Phillips; Susan K. Clark

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 67 KB
Volume: 101
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20416

No coin nor oath required. For personal study only.

✦ Synopsis

tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.

📜 SIMILAR VOLUMES

High-dose tamoxifen and sulindac as firs

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors

✍ Anika Hansmann; Claudia Adolph; Tilmann Vogel; Andreas Unger; Gabriela Moeslein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract ## BACKGROUND Desmoid tumors are mesenchymal nonmetastasizing neoplasms. Although rare in the general population, they are a common extracolonic manifestation of familial adenomatous polyposis (FAP). Because of high tumor recurrence rates, surgery has been less than satisfactory in the

The use of indomethacin, sulindac, and t

The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis

✍ Walter A. Klein; Helen H. Miller; Margaret Anderson; Jerome J. Decosse 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

High-dose dexamethasone as a first- and

High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults

✍ F. Borst; J. J. Keuning; H. van Hulsteijn; H. Sinnige; G. Vreugdenhil 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 90 KB

Fixed dose-rate gemcitabine infusion as

Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree

✍ Alain Gelibter; Paola Malaguti; Serena Di Cosimo; Emilio Bria; Enzo Maria Rugger 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Palliative chemo-radiotherapy with ifosf

Palliative chemo-radiotherapy with ifosfamide and epirubicin as first-line treatment for high-risk metastatic breast cancer

✍ O. F. Lange; W. Scheef; K. D. Haase; M. Heckmann; R. Leyendecker; G. Urban; G. Z 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 460 KB

High-dose chemotherapy as primary treatm

High-dose chemotherapy as primary treatment for poor-risk germ-cell tumors: The Memorial Sloan-Kettering experience (1988–1999)

✍ Michael J. Morris; George J. Bosl 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 100 KB 👁 2 views

Although the majority of patients with poor-risk germ-cell tumors (GCTs) will achieve a durable complete remission (CR) with standard first-line therapy, 20% to 30% of them will either relapse or fail to achieve an initial CR and eventually die. For this reason, the strategy of using high-dose (HD)